Loading…
Loading the latest PSX data…
Loading the latest PSX data…
Highnoon Laboratories Limited (HINOON) against the KSE-100 index: performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-11
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | HINOONPharmaceuticals |
|---|---|
| danioPSX score | 76 |
| Price and size | |
| Price | Rs 962.00 |
| Today | +0.55% |
| Market cap | Rs 51.0bn |
| Traded per day | Rs 11m |
| Valuation and dividends | |
| P/E | 12.4 |
| Dividend yield | 5.4% |
| EPS (last year) | Rs 77.75 |
| Business | |
| EPS growth | +26.6% |
| Sales growth | +11.2% |
| Net margin | 16.0% |
| Returns | |
| 1 month | +4.4% |
| 3 months | −3.8% |
| 1 year | −15.4% |
| vs KSE-100, 1 year | -28.4 pts |
| Trend and risk | |
| 52-week position | 52% |
| RSI 14 | 56 |
| RS rank | 41 |
| Volatility | 31% |
| Beta | 0.71 |
| danioPSX score | |
| Value | 42 |
| Quality | 78 |
| Dividend | 59 |
| Momentum | 43 |
| Safety | 73 |
| Shariah-compliant | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener